PRNewswire/ - MolecuLight Corp., a global pioneer in point-of-care fluorescence imaging for wound care, is proud to showcase ...

SAN JOSE, Calif.--(BUSINESS WIRE)--Evident Vascular, Inc., a medical technology company developing a best-in-class intravascular ultrasound (IVUS) platform powered by artificial intelligence ...

On Philadelphia’s North Broad Street, Dr. Jon George, along with his business partner, Dr. Vincent Varghese, is introducing sophisticated interventional cardiology technology that he says could change ...

MolecuLight Showcases Innovative Multimodal Imaging with Thermal Capabilities at St. Louis Wound & Vascular Symposium Provided by PR Newswire Jun 21, 2025, 10:13:00 AM ...

Finnish startup AIATELLA has raised €2m ($2.27m) in financing to develop and scale its cardiovascular imaging technology powered by AI. The investment will support the company in conducting clinical ...

Evident Vascular, Inc., is developing an advanced intravascular ultrasound (IVUS) platform designed to optimize vascular imaging for peripheral and coronary interventions.

MolecuLight Inc., a global pioneer in point-of-care fluorescence imaging for rapid detection of infection causing bacteria in wounds, is pleased to announce its participation in the Society for Vascul ...

SAN JOSE, Calif., March 25, 2025--Evident Vascular, Inc., a medical technology company developing a best-in-class intravascular ultrasound (IVUS) platform powered by artificial intelligence, today ...

The 26th annual New Cardiovascular Horizons (NCVH) conference brought 1,400 from across the globe to New Orleans to ...

Breye Therapeutics ApS (Breye), a clinical-stage ophthalmology focused biopharmaceutical company developing oral therapeutics for the early treatment of vascular eye diseases, today announces the ...